IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

(Investigative Ophthalmology and Visual Science. 2004;45:3279-3285.)
© 2004 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.04-0576
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (34)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zeng, Y.
Right arrow Articles by Sieving, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zeng, Y.
Right arrow Articles by Sieving, P. A.

RS-1 Gene Delivery to an Adult Rs1h Knockout Mouse Model Restores ERG b-Wave with Reversal of the Electronegative Waveform of X-Linked Retinoschisis

Yong Zeng,1 Yuichiro Takada,1 Sten Kjellstrom,1 Kelaginamane Hiriyanna,1 Atsuhiro Tanikawa,1 Eric Wawrousek,2 Nizar Smaoui,2 Rafael Caruso,2 Ronald A. Bush,1 and Paul A. Sieving1,2

1From the National Institute on Deafness and Other Communication Disorders and the 2National Eye Institute, Bethesda, Maryland.

PURPOSE. To create and evaluate a mouse model of human X-linked juvenile retinoschisis (XLRS) and then investigate whether supplementing with the retinoschisin protein by gene delivery can reverse the abnormal "electronegative" electroretinogram (ERG) retinal response.

METHODS. An X-linked retinoschisis mouse (Rs1h-KO) model was created by substituting a neomycin resistance cassette for exon 1 and 1.6 kb of intron 1 of Rs1h, the murine orthologue of the human RS-1 gene. RS protein was evaluated by immunohistochemistry and Western blot analysis with a polyclonal RS N-terminus antibody. Retinal function was evaluated by conventional, full-field flash ERG recordings. RS protein supplementation therapy was evaluated by gene transfer with an AAV(2/2)-CMV-Rs1h vector containing C57BL/6J Rs1h cDNA under the regulation of a CMV promoter, and ERG functional analysis was performed.

RESULTS. No RS protein was detected by Western blot analysis or immunohistochemistry in the Rs1h-KO mouse. Dark-adapted ERG responses showed an electronegative configuration, with b-wave reduction in both Rs1h–/Y and Rs1h–/– mice, typical of XLRS in humans. Histologic examination of Rs1h-KO mice showed disorganization of multiple retinal layers, including duplication and mislocalization of ganglion cells, laminar dissection through the inner plexiform layer, disorganization of the outer plexiform layer, loss of regularity of the outer nuclear layer, and shortening of the inner/outer segments with mislocalization of photoreceptor nuclei into this layer. After intraocular administration of AAV(2/2)-CMV-Rs1h, immunohistochemistry showed retinoschisin expression in all retinal layers of Rs1h–/Y mice, and ERG recordings showed reversal of the electronegative waveform and restoration of the normal positive b-wave.

CONCLUSIONS. The RS-KO mouse mimics structural features of human X-linked juvenile retinoschisis with dissection through, and disorganization of, multiple retinal layers. The Rs1h-KO functional deficit results in an electronegative ERG waveform that is characteristic of human retinoschisis disease and that implicates a synaptic transmission deficit in the absence of retinoschisin protein. Replacement therapy by supplementing normal Rs1h protein in the adult Rs1h-KO mouse restored the normal ERG configuration. This indicates that gene therapy is a viable strategy of therapeutic intervention even in the postdevelopmental adult stage of XLRS disease.




This article has been cited by other articles:


Home page
 IOVSHome page
Y. Takada, C. Vijayasarathy, Y. Zeng, S. Kjellstrom, R. A. Bush, and P. A. Sieving
Synaptic Pathology in Retinoschisis Knockout (Rs1-/y) Mouse Retina and Modification by rAAV-Rs1 Gene Delivery
Invest. Ophthalmol. Vis. Sci., August 1, 2008; 49(8): 3677 - 3686.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
C. Gerth, R. J. Zawadzki, J. S. Werner, and E. Heon
Retinal Morphological Changes of Patients With X-linked Retinoschisis Evaluated by Fourier-Domain Optical Coherence Tomography
Arch Ophthalmol, June 1, 2008; 126(6): 807 - 811.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
M. L. Ko, Y. Liu, L. Shi, D. Trump, and G. Y.-P. Ko
Circadian Regulation of Retinoschisin in the Chick Retina
Invest. Ophthalmol. Vis. Sci., April 1, 2008; 49(4): 1615 - 1621.
[Abstract] [Full Text] [PDF]

Home page
 GeneticsHome page
B. A. Johnson, N. Aoyama, N. H. Friedell, S. Ikeda, and A. Ikeda
Genetic Modification of the Schisis Phenotype in a Mouse Model of X-Linked Retinoschisis
Genetics, March 1, 2008; 178(3): 1785 - 1794.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
M. Allocca, C. Mussolino, M. Garcia-Hoyos, D. Sanges, C. Iodice, M. Petrillo, L. H. Vandenberghe, J. M. Wilson, V. Marigo, E. M. Surace, et al.
Novel Adeno-Associated Virus Serotypes Efficiently Transduce Murine Photoreceptors
J. Virol., October 15, 2007; 81(20): 11372 - 11380.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
S. C. Khani, B. S. Pawlyk, O. V. Bulgakov, E. Kasperek, J. E. Young, M. Adamian, X. Sun, A. J. Smith, R. R. Ali, and T. Li
AAV-Mediated Expression Targeting of Rod and Cone Photoreceptors with a Human Rhodopsin Kinase Promoter
Invest. Ophthalmol. Vis. Sci., September 1, 2007; 48(9): 3954 - 3961.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
S. Kjellstrom, R. A. Bush, Y. Zeng, Y. Takada, and P. A. Sieving
Retinoschisin Gene Therapy and Natural History in the Rs1h-KO Mouse: Long-term Rescue from Retinal Degeneration
Invest. Ophthalmol. Vis. Sci., August 1, 2007; 48(8): 3837 - 3845.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
F. M. Dyka and R. S. Molday
Coexpression and Interaction of Wild-type and Missense RS1 Mutants Associated with X-Linked Retinoschisis: Its Relevance to Gene Therapy
Invest. Ophthalmol. Vis. Sci., June 1, 2007; 48(6): 2491 - 2497.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
S. K Sikkink, S. Biswas, N. R A Parry, P. E Stanga, and D. Trump
X-linked retinoschisis: an update
J. Med. Genet., April 1, 2007; 44(4): 225 - 232.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
C. Vijayasarathy, Y. Takada, Y. Zeng, R. A. Bush, and P. A. Sieving
Retinoschisin Is a Peripheral Membrane Protein with Affinity for Anionic Phospholipids and Affected by Divalent Cations
Invest. Ophthalmol. Vis. Sci., March 1, 2007; 48(3): 991 - 1000.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
P. J. DeMarco Jr, G. L. Yarbrough, C. W. Yee, G. Y. McLean, B. T. Sagdullaev, S. L. Ball, and M. A. McCall
Stimulation via a Subretinally Placed Prosthetic Elicits Central Activity and Induces a Trophic Effect on Visual Responses
Invest. Ophthalmol. Vis. Sci., February 1, 2007; 48(2): 916 - 926.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
S. H. Tsang, V. Vaclavik, A. C. Bird, A. G. Robson, and G. E. Holder
Novel Phenotypic and Genotypic Findings in X-Linked Retinoschisis
Arch Ophthalmol, February 1, 2007; 125(2): 259 - 267.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Ophthalmol.Home page
T Wang, A Zhou, C T Waters, E O'Connor, R J Read, and D Trump
Molecular pathology of X linked retinoschisis: mutations interfere with retinoschisin secretion and oligomerisation
Br. J. Ophthalmol., January 1, 2006; 90(1): 81 - 86.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the Association for Research in Vision and Ophthalmology